Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.

Rannikmäe K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, Al-Shahi Salman R, Sudlow CL.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):300-5. doi: 10.1136/jnnp-2013-306485. Epub 2013 Oct 25.

2.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

3.

Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.

Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, Hyman BT, Rebeck GW.

Neurology. 1998 Apr;50(4):961-5.

PMID:
9566379
4.

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature.

Nelson PT, Pious NM, Jicha GA, Wilcock DM, Fardo DW, Estus S, Rebeck GW.

J Neuropathol Exp Neurol. 2013 Jul;72(7):708-15. doi: 10.1097/NEN.0b013e31829a25b9.

5.

Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes.

Charidimou A, Martinez-Ramirez S, Shoamanesh A, Oliveira-Filho J, Frosch M, Vashkevich A, Ayres A, Rosand J, Gurol ME, Greenberg SM, Viswanathan A.

Neurology. 2015 Mar 24;84(12):1206-12. doi: 10.1212/WNL.0000000000001398. Epub 2015 Feb 25.

6.

APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study.

Biffi A, Anderson CD, Jagiella JM, Schmidt H, Kissela B, Hansen BM, Jimenez-Conde J, Pires CR, Ayres AM, Schwab K, Cortellini L, Pera J, Urbanik A, Romero JM, Rost NS, Goldstein JN, Viswanathan A, Pichler A, Enzinger C, Rabionet R, Norrving B, Tirschwell DL, Selim M, Brown DL, Silliman SL, Worrall BB, Meschia JF, Kidwell CS, Broderick JP, Greenberg SM, Roquer J, Lindgren A, Slowik A, Schmidt R, Woo D, Rosand J; International Stroke Genetics Consortium.

Lancet Neurol. 2011 Aug;10(8):702-9. doi: 10.1016/S1474-4422(11)70148-X. Epub 2011 Jul 6.

7.

Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis.

Rannikmäe K, Samarasekera N, Martînez-Gonzâlez NA, Al-Shahi Salman R, Sudlow CL.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):901-8. doi: 10.1136/jnnp-2012-303898. Epub 2013 Mar 2. Review.

PMID:
23457231
8.

APOE and cerebral amyloid angiopathy in community-dwelling older persons.

Yu L, Boyle PA, Nag S, Leurgans S, Buchman AS, Wilson RS, Arvanitakis Z, Farfel JM, De Jager PL, Bennett DA, Schneider JA.

Neurobiol Aging. 2015 Nov;36(11):2946-2953. doi: 10.1016/j.neurobiolaging.2015.08.008. Epub 2015 Aug 15.

9.

APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.

Nicoll JA, McCarron MO.

Amyloid. 2001 Jul;8 Suppl 1:51-5.

PMID:
11676291
10.

Cerebral hemorrhage and apoE.

Garcia C, Pinho e Melo T, Rocha L, Lechner MC.

J Neurol. 1999 Sep;246(9):830-4.

PMID:
10525983
11.

Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.

Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S.

Neuropathol Appl Neurobiol. 2005 Dec;31(6):589-99.

PMID:
16281907
12.

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.

Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, Jimenez-Conde J, Hansen BM, Fernandez-Cadenas I, Cortellini L, Ayres A, Schwab K, Juchniewicz K, Urbanik A, Rost NS, Viswanathan A, Seifert-Held T, Stoegerer EM, Tomás M, Rabionet R, Estivill X, Brown DL, Silliman SL, Selim M, Worrall BB, Meschia JF, Montaner J, Lindgren A, Roquer J, Schmidt R, Greenberg SM, Slowik A, Broderick JP, Woo D, Rosand J; International Stroke Genetics Consortium.

Ann Neurol. 2010 Dec;68(6):934-43. doi: 10.1002/ana.22134.

13.

The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S, Graham DI, Dewar D.

J Neuropathol Exp Neurol. 1999 Jul;58(7):711-8.

PMID:
10411341
14.

Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors.

McCarron MO, Nicoll JA, Ironside JW, Love S, Alberts MJ, Bone I.

Stroke. 1999 Aug;30(8):1643-6.

15.

Two types of sporadic cerebral amyloid angiopathy.

Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Del Tredici K, Braak H.

J Neuropathol Exp Neurol. 2002 Mar;61(3):282-93.

PMID:
11895043
16.

Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.

Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV.

JAMA Neurol. 2014 Jul 1;71(7):878-83. doi: 10.1001/jamaneurol.2014.681.

17.
18.

Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.

Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT.

Ann Neurol. 1995 Aug;38(2):254-9.

PMID:
7654074
19.

Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Su WH, Shi ZH, Liu SL, Wang XD, Liu S, Ji Y.

Oncotarget. 2017 Jul 4;8(27):43721-43732. doi: 10.18632/oncotarget.17341.

20.

Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.

Rosand J, Hylek EM, O'Donnell HC, Greenberg SM.

Neurology. 2000 Oct 10;55(7):947-51.

PMID:
11061249

Supplemental Content

Support Center